BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 11160865)

  • 1. Sensitivity of monkey B virus (Cercopithecine herpesvirus 1) to antiviral drugs: role of thymidine kinase in antiviral activities of substrate analogs and acyclonucleosides.
    Focher F; Lossani A; Verri A; Spadari S; Maioli A; Gambino JJ; Wright GE; Eberle R; Black DH; Medveczky P; Medveczky M; Shugar D
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2028-34. PubMed ID: 17438061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between spontaneous telomere loss and chromosome instability in a human tumor cell line.
    Fouladi B; Sabatier L; Miller D; Pottier G; Murnane JP
    Neoplasia; 2000; 2(6):540-54. PubMed ID: 11228547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic introns enable splicing factor mutation-dependent targeting of cancer cells.
    North K; Benbarche S; Liu B; Pangallo J; Chen S; Stahl M; Bewersdorf JP; Stanley RF; Erickson C; Cho H; Pineda JMB; Thomas JD; Polaski JT; Belleville AE; Gabel AM; Udy DB; Humbert O; Kiem HP; Abdel-Wahab O; Bradley RK
    Nat Biotechnol; 2022 Jul; 40(7):1103-1113. PubMed ID: 35241838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzymes to die for: exploiting nucleotide metabolizing enzymes for cancer gene therapy.
    Ardiani A; Johnson AJ; Ruan H; Sanchez-Bonilla M; Serve K; Black ME
    Curr Gene Ther; 2012 Apr; 12(2):77-91. PubMed ID: 22384805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering Kinases to Phosphorylate Nucleoside Analogs for Antiviral and Cancer Therapy.
    Lutz S; Liu L; Liu Y
    Chimia (Aarau); 2009 Nov; 63(11):737-744. PubMed ID: 20305804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intercellular trafficking and cytotoxicity of recombinant HSV-1 thymidine kinase fused with HSV-2 US11 RXP repeat peptide.
    Luo C; Nawa A; Yamauchi Y; Kohno S; Ushijima Y; Goshima F; Kikkawa F; Nishiyama Y
    Virus Genes; 2007 Jun; 34(3):263-72. PubMed ID: 16927131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU).
    De Clercq E
    Med Res Rev; 2005 Jan; 25(1):1-20. PubMed ID: 15389733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bicyclic pyrimidine nucleoside analogues (BCNAs) as highly selective and potent inhibitors of varicella-zoster virus replication.
    Balzarini J; McGuigan C
    J Antimicrob Chemother; 2002 Jul; 50(1):5-9. PubMed ID: 12096000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective abolishment of pyrimidine nucleoside kinase activity of herpes simplex virus type 1 thymidine kinase by mutation of alanine-167 to tyrosine.
    Degrève B; Esnouf R; De Clercq E; Balzarini J
    Mol Pharmacol; 2000 Dec; 58(6):1326-32. PubMed ID: 11093770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative cytostatic activity of different antiherpetic drugs against herpes simplex virus thymidine kinase gene-transfected tumor cells.
    Balzarini J; Bohman C; Walker RT; de Clercq E
    Mol Pharmacol; 1994 Jun; 45(6):1253-8. PubMed ID: 8022417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymidylate synthase is the principal target enzyme for the cytostatic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine against murine mammary carcinoma (FM3A) cells transformed with the herpes simplex virus type 1 or type 2 thymidine kinase gene.
    Balzarini J; De Clercq E; Verbruggen A; Ayusawa D; Shimizu K; Seno T
    Mol Pharmacol; 1987 Sep; 32(3):410-6. PubMed ID: 2823092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential mechanism of cytostatic effect of (E)-5-(2-bromovinyl)-2'-deoxyuridine, 9-(1,3-dihydroxy-2-propoxymethyl)guanine, and other antiherpetic drugs on tumor cells transfected by the thymidine kinase gene of herpes simplex virus type 1 or type 2.
    Balzarini J; Bohman C; De Clercq E
    J Biol Chem; 1993 Mar; 268(9):6332-7. PubMed ID: 8384209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selection of HSV-1 TK gene-transfected murine mammary carcinoma cells resistant to (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and ganciclovir (GCV).
    Degrève B; De Clercq E; Balzarini J
    Gene Ther; 2000 Sep; 7(18):1543-52. PubMed ID: 11021592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation of Gln125 to Asn selectively abolishes the thymidylate kinase activity of herpes simplex virus type 1 thymidine kinase.
    Degrève B; Esnouf R; De Clercq E; Balzarini J
    Mol Pharmacol; 2001 Feb; 59(2):285-93. PubMed ID: 11160865
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.